The Downstream Processing Market is entering a high-stakes expansion phase driven by surging biopharmaceutical production, intensified demand for monoclonal antibodies, and rapid scale-up of cell and ...
In this webinar, our speaker will explore a series of practical, chromatography-focused strategies designed to enhance mAb purification performance while reducing cost of goods (COGs).
Process intensification has reduced the cost of mAb manufacturing, but tweaks across bioproduction will be needed to reduce ...
Biomanufacturing might appear to be centered around the cell line, which does enjoy a certain pride of place, ensconced as it is in the bioreactor, where conditions are carefully monitored and ...
Over the last few years, the number of recombinant pharmaceutical products that have entered the regulatory fray to gain approval for marketing has grown rapidly, and is now in the hundreds. As ...
Biopharmaceutical downstream processing requires precise control of multiple unit operations—from chromatography and filtration to viral inactivation—to ensure product quality and therapeutic efficacy ...
LEWES, Del., April 15, 2026 /PRNewswire/ -- The Global Downstream Processing Market is projected to grow at a CAGR of 6.8% from 2026 to 2033, according to a new report published by Verified Market ...
The Downstream Processing Market is entering a high-stakes expansion phase driven by surging biopharmaceutical production, intensified demand for monoclonal antibodies, and rapid scale-up of cell and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results